Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Pathology Laboratory Network (MPLN) is a specialized reference laboratory providing high-complexity diagnostic services in oncology, hematopathology, and infectious diseases. The company offers a comprehensive menu of molecular diagnostics, including next-generation sequencing (NGS), flow cytometry, and cytogenetics, to support clinical decision-making and personalized medicine. Beyond clinical testing, MPLN serves as a contract research organization (CRO) providing laboratory support for clinical trials and drug development. The company is accredited by the College of American Pathologists (CAP) and is CLIA-certified, ensuring high standards for genomic and pathology services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Pathology.